CDTVSGTBP• 28 Days (Normalized)
CDT vs GTBP (CDT Equity Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Aug 28 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CDT Performance $0.14
-92.01%
CDT Equity Inc.
Normalized Baseline0.00%
GTBP Performance $7.1
+2266.67%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-2358.68 pts
GTBP outperforming by 2358.68 percentage points
CDTGTBP
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CDT GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(18 dates)
| Date | CDT Price | CDT Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $0.14 | -92.01% | $7.10 | +2266.67% | -2358.68% |
| Sep 22, 2026 | $0.14 | -91.60% | $- | - | |
| Sep 21, 2026 | $0.15 | -90.89% | $7.18 | +2293.33% | -2384.22% |
| Sep 18, 2026 | $0.17 | -89.70% | $7.16 | +2286.67% | -2376.37% |
| Sep 17, 2026 | $0.19 | -88.76% | $7.49 | +2396.67% | -2485.43% |
| Sep 16, 2026 | $0.20 | -88.28% | $7.81 | +2503.33% | -2591.61% |
| Sep 15, 2026 | $0.20 | -87.99% | $9.00 | +2900.00% | -2987.99% |
| Sep 14, 2026 | $0.22 | -87.04% | $11.63 | +3776.67% | -3863.71% |
| Sep 11, 2026 | $0.25 | -85.21% | $8.61 | +2770.00% | -2855.21% |
| Sep 10, 2026 | $0.35 | -79.59% | $6.18 | +1960.00% | -2039.59% |
| Sep 09, 2026 | $0.60 | -64.50% | $5.98 | +1893.33% | -1957.83% |
| Sep 08, 2026 | $0.62 | -63.49% | $- | - | |
| Sep 04, 2026 | $0.63 | -63.02% | $0.24 | -19.67% | -43.35% |
| Sep 03, 2026 | $0.75 | -55.68% | $0.25 | -16.00% | -39.68% |
| Sep 02, 2026 | $0.91 | -46.15% | $0.28 | -5.67% | -40.48% |
Page 1 of 2